AfterGlow @ AACC August 2, 2016

during the AACC

Annual Meeting

The POC Social of the Year!

More > | Register!

POCC Forum

August 4, 2016  during the AACC Annual Meeting

Talking the Talk...

More > | Register!

  | Contact UsHome

Starting a POC Group >

POCC of the Year >

POC Vendors >

Publications >

POC Procedures >

On this Page...

Top 10 Deficiencies in the Laboratory | GO >

Glucose PT Criteria Stirs Debate | GO >

POC Awards | GO >

More Clarity for Heart Failure Biomarkers | GO >

The Next Step for Molecular POCT | GO >

Medical Errors 3rd Leading Cause of Death |  GO >

Zika Virus Puts Testing in the Forefront | GO >

With High-Sensitivity Troponins, Watching and Waiting Continue | GO >

Making a Smooth Pivot to Point-of-Care IQCP | GO >

POCT in the ED | GO >

AACC Launches Express Membership | GO >

POC Groups

3Rivers (Western PA)



Baltimore/Chesapeake Bay

Bay Area (CA) 

Bay State (MA) 

Capitol (DC)

Central Florida 



First Coast Florida


Heart of America 




New Jersey 

New York City 

North Carolina

North Country (MN)

North Texas

Northwest (OR)


Ontario (CN) 

Puget Sound (WA) 

Rocky Mountain

San Diego 

South Carolina

Southern California 

Southwest Florida 



Texas Gulf Coast

Tri-State (IL) 

Upstate NY 



NACB Guidelines

Journal of Point of Care Testing

POC Demographics Survey


POC Meeting, Webinars, and Events Calendar

2016 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Have a POC meeting or event? Send the details here so we can post on the calendar.


CLSI Solution Packages Cover

Top 10 Deficiencies in the Laboratory

CLSI identified the top 10 most commonly cited deficiencies by major accreditation organizations, and created solution packages to address each area. Each package is designed to provide you with the tools to prepare for accreditation inspection, improve areas of interest, or resolve any deficiencies cited on your last inspection. Packages include:


  • Controls: Mean and Standard Deviation
  • Specimen and Reagent Storage
  • Personnel Records, Responsibilities, and Competence
  • Lab Director Responsibilities
  • Waived and Quantitative QC
  • Patient and Specimen Identification
  • Method Validation and Verification
  • Method Correlation
  • Proficiency Testing
  • Adverse and Nonconforming Events

More on CLSI Solution Packages >

Glucose Proficiency Testing Criteria Reset

Stirs Standards Debate
By Anne Paxton, CAP Today, June 2016

It may not be an exact science, but resetting standards is a long-established means of improving quality of testing, and it can also be a way of adapting to improvements in quality that have already been realized. In the case of the CAP’s recent tightening of proficiency testing criteria for hospital glucose testing, both purposes are at work. The new criteria reflect the fact that glucose meter performance has improved significantly, CAP Chemistry Resource Committee chair Gary L. Horowitz, MD, explains in the 2016 Program Update on Glucose Meter Performance. But the change in Survey criteria has brought unexpected pushback from one of the leading hospital glucose meter manufacturers.

The CAP’s Chemistry Resource Committee approved and implemented the new PT grading criteria for hospital glucose meter performance in early 2015. The cutoff for passing was changed from within... Read more >

AACC POC Award Winners | More

Kerstin Halverson Named

2016 POCC of the Year

The AACC CPOCT Division has announced that Kerstin Halverson of Children’s of Minnesota has been named the 2016 Point of Care Coordinator of the Year. Since 2003, Kerstin has overseen the entire POCT program for two hospitals, one ambulatory surgery center, three clinics and one ancillary testing site.  Read more >

Pat Kraft Receives 2016 Outstanding Contributions to POCT Award

Patricia Kraft, M.A., MT (ASCP), Laboratory POCT/Safety/Education Coordinator at Good Samaritan Hospital in Dayton, Ohio is the recipient of the 2016 Outstanding Contributions to POCT Award. Pat graduated with a BS in Medical Technology from the University of Dayton... More>

More Clarity Over Time for Heart Failure Biomarkers
By Karen Lusky, CAP Today, June 2016

Robert Christenson, PhD, a professor of pathology and of medical and research technology at the University of Maryland School of Medicine, likens the U.S. mortality rate for myocardial infarction to three or four jumbo jets crashing daily. For heart failure, it’s about half that many deaths, “so maybe one and one-half jumbo jets,” Dr. Christenson said in a session on cardiac biomarkers at the CAP annual meeting last year. With more people living longer in general but surviving acute MI, said co-presenter and cardiologist Christopher deFilippi, MD, “we are seeing..." Read more >

The Next Step for Molecular POCT
Shrinking Technology and Tighter Turnaround Times Shake Up the Field
By Julie Kirkwood, Clinical Laboratory News, June 2016

The year 2015 may well be remembered as the the time when molecular diagnostics began to expand beyond the laboratory. In January, the Food and Drug Administration (FDA) granted its first CLIA waiver to a nucleic acid-based test, the Alere i Influenza A&B. A few months later, Roche received a CLIA waiver for the cobas Liat System and Strep A. By the end of the year, Alere’s i Strep A, Roche’s Liat influenza A & B, and Cepheid’s Xpert Flu+RSV Xpress had also received CLIA waivers.

Read more > | Molecular Platforms on the market >

Medical Errors Are the Third Leading Cause

of Death in the US
Fatal mistakes, which account for more than 250,000 deaths each year, merit a closer look
June 2016, Clinical Laboratory News

Fatal medical errors—whether occurring by omission or commission—go unmentioned on death certificates and are not tracked by the Centers for Disease Control and Prevention (CDC).  A new analysis published May 3 in the BMJ, however, suggests these mistakes merit a closer look. By examining four prior studies that reported such deaths between 2000 and 2008, and then making new calculations based on the hospital admission rate in 2013, researchers estimated that 251,454 deaths that year stemmed from medical errors. This amounts to 9.5% of all deaths each year in the U.S, they say. Read more >

Zika Virus Puts Testing in the Forefront
Major new funding, testing sought as disease rages
By Gary Tufel, Clinical Lab Products, May 2016


One of the biggest healthcare surprises of the past year has been the sudden and frightening rise to prominence of the Zika virus in the Western Hemisphere. An arbovirus spread predominantly by the Aedes aegypti mosquito, Zika typically causes a mild illness whose symptoms include conjunctivitis, fever, joint pain, and rash lasting several days to a week. Previously thought to be a mild virus that resulted in symptoms for only about 20% of those infected, Zika is turning out to be the cause of a number of serious diseases. Of special concern is recent definitive evidence that the virus causes microcephaly in infants as well as causing serious brain and nerve cell damage. Read more >

With High-Sensitivity Troponins,

Watching and Waiting Continue
By Karen Lusky, CAP Today, May 2016


Laboratories and hospitals in the U.S. continue to look forward to high-sensitivity troponin assays. Judd E. Hollander, MD, says all he’s heard for the past five years is that an assay will be out at the end of the year. “And once you get halfway through the year, it will be out next year,” says Dr. Hollander, chair of the Department of Emergency Medicine and associate dean of strategic health initiatives at Sidney Kimmel Medical College of Thomas Jefferson University. Robert Christenson, PhD, DABCC, professor of pathology at the University of Maryland School of Medicine, sees the odds as good that the FDA will clear one such assay this year. He predicts it will be a Roche or an Abbott assay.

Agim Beshiri, MD, Abbott’s senior medical director of global medical and scientific affairs for diagnostics, says, “The requirements for U.S. regulatory approval for any troponin test are very high, and the complexity is enhanced with high-sensitivity troponin methods. It is not possible to predict when these tests will become available.” Read more >

Making a Smooth Pivot to Point-of-Care IQCP
By Anne Paxton, CAP Today, May 2016

Practically speaking, there’s a limit to the number of balls a human can juggle. And there’s probably a limit to how complex a quality control plan a point-of-care testing coordinator can handle. Last year, many POC coordinators felt that the Centers for Medicare and Medicaid Services would be pushing that limit pretty hard with its new Individualized Quality Control Plan. The voluntary-in-name-only QC program had a Jan. 1 deadline, but Adonica Wilson, MT(ASCP) (right), confesses that when she contemplated developing an IQCP, she procrastinated a little, in hopes that the program would somehow get canceled.

“I was one of those ones holding out hope that something would change before the end of 2015,” Wilson says. So, as point-of-care coordinator for Nemours/Alfred I. duPont Hospital for Children in Wilmington, Del., she left only a month or two to complete her IQCPs before the Jan. 1 deadline. Still, she was pretty well prepared. “We knew it was coming, and I had been going to seminars and webinars on it for the last two years.”

Read more >

This is the second in a series. Previously: IQCP without agony at the point of care

POCT in the Emergency Department
The healthcare industry has realized the value of POCT

as an option in emergencies
By Benjamin Roussel, PharmD, Advance for the Administrators of the Laboratory, May 2016


Point-of-care testing (POCT) refers to the performance of analytical tests on patient specimens outside of the laboratory by inexperienced staff. Among the existing point-of-care tests, there are two different types: simple lateral flow tests (pregnancy, HIV, glucose or even drugs-of-abuse (DOA) testing), where no complex fluid management is required and complex microfluidics-based tests. POCT testing based on microfluidic technology is expected to grow from $2.7 billion in 2015 to $7.4 billion in 2019-with a compound annual growth rate of 23% between 2015-2020.  Read more >

AACC Launches Express Membership Category

$65 Annual Fee Provides Numerous Association Benefits

Great news for POCCs and Exclusively for New Members, AACC’s New Express Membership enables you to benefit from a wide range of resources at an affordable dues level, including:
Access to AACC’s online networking opportunities; Select educational programs, and News publications.


One of the essential ways that AACC members convene is online through the members-only AACC Artery. Discussions cover a range of topics from the challenges of monitoring point-of-care testing compliance to practical lab fundamentals, such as critical values and specimen types and retention. For more details, and to sign up, visit the Express Member page!

Click here for more stories in our Article Archives...



Quality Control

EP Evaluator®

Last updated: 06/28/2016 Questions or corrections: © 2016  BACK TO TOP